These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 8652559
1. Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins. Kane SA, Lippard SJ. Biochemistry; 1996 Feb 20; 35(7):2180-8. PubMed ID: 8652559 [Abstract] [Full Text] [Related]
2. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Ohndorf UM, Rould MA, He Q, Pabo CO, Lippard SJ. Nature; 1999 Jun 17; 399(6737):708-12. PubMed ID: 10385126 [Abstract] [Full Text] [Related]
3. Laser-induced photo-cross-linking of cisplatin-modified DNA to HMG-domain proteins. Mikata Y, He Q, Lippard SJ. Biochemistry; 2001 Jun 26; 40(25):7533-41. PubMed ID: 11412107 [Abstract] [Full Text] [Related]
5. Binding of Ixr1, a yeast HMG-domain protein, to cisplatin-DNA adducts in vitro and in vivo. McA'Nulty MM, Whitehead JP, Lippard SJ. Biochemistry; 1996 May 14; 35(19):6089-99. PubMed ID: 8634251 [Abstract] [Full Text] [Related]
6. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities. Trimmer EE, Zamble DB, Lippard SJ, Essigmann JM. Biochemistry; 1998 Jan 06; 37(1):352-62. PubMed ID: 9425057 [Abstract] [Full Text] [Related]
7. A single HMG domain in high-mobility group 1 protein binds to DNAs as small as 20 base pairs containing the major cisplatin adduct. Chow CS, Barnes CM, Lippard SJ. Biochemistry; 1995 Mar 07; 34(9):2956-64. PubMed ID: 7893709 [Abstract] [Full Text] [Related]
8. DNA sequence context modulates the impact of a cisplatin 1,2-d(GpG) intrastrand cross-link on the conformational and thermodynamic properties of duplex DNA. Pilch DS, Dunham SU, Jamieson ER, Lippard SJ, Breslauer KJ. J Mol Biol; 2000 Feb 25; 296(3):803-12. PubMed ID: 10677282 [Abstract] [Full Text] [Related]
15. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)]. Brabec V, Christofis P, Slámová M, Kostrhunová H, Nováková O, Najajreh Y, Gibson D, Kaspárková J. Biochem Pharmacol; 2007 Jun 15; 73(12):1887-900. PubMed ID: 17400194 [Abstract] [Full Text] [Related]
16. Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin. Takahara PM, Rosenzweig AC, Frederick CA, Lippard SJ. Nature; 1995 Oct 19; 377(6550):649-52. PubMed ID: 7566180 [Abstract] [Full Text] [Related]
17. Nature of full-length HMGB1 binding to cisplatin-modified DNA. Jung Y, Lippard SJ. Biochemistry; 2003 Mar 11; 42(9):2664-71. PubMed ID: 12614161 [Abstract] [Full Text] [Related]
18. HMG-domain protein recognition of cisplatin 1,2-intrastrand d(GpG) cross-links in purine-rich sequence contexts. Cohen SM, Mikata Y, He Q, Lippard SJ. Biochemistry; 2000 Sep 26; 39(38):11771-6. PubMed ID: 10995245 [Abstract] [Full Text] [Related]
19. Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies. Kaspárková J, Mellish KJ, Qu Y, Brabec V, Farrell N. Biochemistry; 1996 Dec 24; 35(51):16705-13. PubMed ID: 8988007 [Abstract] [Full Text] [Related]
20. Single d(GpG)/cis-diammineplatinum(II) adduct-induced inhibition of DNA polymerization. Suo Z, Lippard SJ, Johnson KA. Biochemistry; 1999 Jan 12; 38(2):715-26. PubMed ID: 9888812 [Abstract] [Full Text] [Related] Page: [Next] [New Search]